http://rdf.ncbi.nlm.nih.gov/pubchem/patent/SU-1053756-A3
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d709e3167fa2f99a1803c9cfeb0aca63 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D457-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-12 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D457-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D519-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-48 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-12 |
| filingDate | 1981-04-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 1983-11-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2e144fdccc9be3e161c7489e226d3cd9 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_89ce2adc06d9c3ce59e945f4747d6265 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_711c459584a07231506ddef4b6ed1733 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_92ec3de287eff870a1732a9ff425144e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f691fdf716b95e95b92ba0fffc592aa6 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c6f87051c34f0b1ca5a208e8f4ea5e8c |
| publicationDate | 1983-11-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | SU-1053756-A3 |
| titleOfInvention | Process for preparing ergoline derivatives or their salts |
| abstract | 1. A method for producing ergoline derivatives of the general formula: Hee R ,, and R2 is hydrogen or metal; Rj is hydrogen or methoxy} l-C-C-alkyl or C-C ashonyl; Rg and R C C.-alkyl, cyclohexyl or (H-aimethylamino) -C-Cd-alkyl with the proviso that R is not (G1-dimethylamino) -C-C-alkyl, or their salts with an organic or nonorganic acid wherein the common formula COOH, w where R ,, R is tftvieroT the indicated values, i is brought into interaction with the compound of the general formula Rj-N C - NR / where Ye and Rg have the indicated values with the subsequent isolation of the target products in in free form or as O salts with organic or inorganic SLE acid. , 2. The method according to claim 1, that is, that the interaction of G5 is carried out in tetragitsrofuran; 3. The method according to article 1, that is, t the fact that the process is carried out. at 50–100 s for 5–24 h. |
| priorityDate | 1980-04-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 100.